改善移植后的预后:一种可解释的机器学习方法,用于纵向预测结果
Bowen Fan1, Manuel Schürch2, Yuan Tian3
1University of Zurich, Zurich, Switzerland. bowen.fan@uzh.ch.
NPJ digital medicine
|November 18, 2025
概括
这项研究引入了一种动态机器学习 (ML) 模型,用于每年预测移植移植的移植损失和患者死亡. 通过使用随时间推移的纵向患者数据,ML方法可以提高风险预测的准确性.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 移植医学 移植医学
- 生物医学数据科学 生物医学数据科学
背景情况:
- 移植是末期病的拯救性治疗方法.
- 长期的移植存活率和患者死亡率仍然是移植后的重大挑战.
- 现有的预测模型往往缺乏动态更新功能,限制了它们的长期效用.
研究的目的:
- 开发和验证一个两阶段的机器学习 (ML) 框架,用于动态,每年预测移植受体中移植损失和死亡的风险.
- 评估通过结合纵向数据与仅基线模型相比,通过结合纵向数据获得的性能改善.
- 为准确和可解释的风险分层确定最有效的ML模型.
主要方法:
- 使用了来自瑞士移植队列研究 (STCS) 的多中心队列,使用了13年的随访数据.
- 开发了一个两阶段的ML框架,用于动态的年度风险预测.
- 训练并评估了五个ML模型,包括LightGBM,比较纵向与基线数据输入.
主要成果:
- 整合纵向数据显著提高了预测性能,而不是仅使用基线模型.
- 轻GBM模型表现出卓越的性能,实现了AUROC的0.896的移植损失和0.797的死亡.
- 动态ML模型在预测患者和移植结果方面提供了更高的准确性.
结论:
- 动态,可解释的ML模型为移植中个性化风险分层提供了实用和可扩展的方法.
- 这些模型可以帮助指导为移植受体量身定制的后续策略和及时干预.
- 改善风险预测可以为移植患者带来更好的长期结果.
更多相关视频
04:09Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
Published on: October 10, 2018
8.6K
09:00TBase - an Integrated Electronic Health Record and Research Database for Kidney Transplant Recipients
Published on: April 13, 2021
5.2K
相关概念视频
01:28Kidney Transplant I: Introduction
312
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
312
01:16Kidney Transplant III: Nursing Management
298
Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
298
01:26Kidney Transplant II: Surgical Procedure
290
Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
290
01:29Acute Kidney Injury III: Clinical Manifestations
785
Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
785
01:25Chronic Kidney Disease I: Introduction
549
Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
549
01:20Actuarial Approach
280
The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
280